Novabay Pharmaceuticals Inc.

13F holders, Q1 2024 (March 31)
1holders
$0.10avg. 13F price*

At the end of Q1 2024, 1 institutions reported holding Novabay Pharmaceuticals Inc. in their 13F filings. The largest holder was Nvwm, LLC ($9).

Company
Novabay Pharmaceuticals Inc.
CUSIP
66987P201
Latest filing quarter
Q1 2024

Total Exit/New Position Q1 2024

InstitutionsTotal Value
New Positions0$0
Exits1$1

Ownership 1 holders

Nvwm, LLC 0.00% No change 86 $9

"% of holder's portfolio" is NOVABAY PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Novabay Pharmaceuticals Inc. the manager owns.